Shanghai, China – On April 9, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") was awarded "2017 Shanghai Brand Cultivation Demonstration Enterprise" by Shanghai Municipal Commission of Economy and Information.

Shanghai Municipal Commission of Economy and Information initiated the selection of Brand Cultivation Demonstration Enterprise aiming to cultivate a group of enterprises with independent brand and international competitiveness. Companies winning the title are mostly industry leaders with good brand image. The applicants will be strictly screened by government authorities based on their social awareness, industry position, innovative ability, and etc. The applicants have to go through several rounds of review before they win the title of "Shanghai Top Brand". Only companies with independent intellectual property, strong probability and competiveness are qualified to apply for the selection.

MicroPort® Endovascular has always been striving for innovation to promote the development of independent brands. It primarily focuses on R&D, manufacturing, sales and technical support of the interventional medical devices, including AAA/TAA stent graft systems, surgical stent graft system, aortic balloon dilation catheter and peripheral vascular stents/balloons. Its devices are widely used in China's top hospitals and have been exported to countries and regions in South America and Southeast Asia. As it is selected as this year's "Shanghai Brand Cultivation Demonstration Enterprise" it demonstrated the increasing brand awareness of MicroPort® Endovascular with its leading position in terms of product quality and company governance. In the future, MicroPort® Endovascular will continue to carry out the management credo of "Eyes for Greatness, Hands on Details" to offer cost-effective medical solutions to save or reshape lives or improve the quality of life for patients in China and worldwide.